AN 982Alternative Names: Morphine-hydrochloride; OPSO
Latest Information Update: 10 Jul 2014
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Dainippon Pharma
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer pain